A patch that looks like a bandage.

The monitoring starts itself.

No pairing. No charging. No troubleshooting.

The Problem

Patient monitoring is still mostly manual.

0

How often a nurse manually checks vitals

0

Time taken per manual check

0

Rapid response calls that were preventable

"We spent months trying to crack a competitor's proprietary protocol. The lesson wasn't just technical — it was clinical. A device that requires that much infrastructure will never reach the patients who need it most."

— ARGOS founding team
ARGOS Patch worn on patient wrist

ARGOS Patch

Disposable. Open BLE. AI-scored.

Peel the patch
01

Peel

Remove the liner. The adhesive is medical-grade, gentle on skin, and repositionable for 30 seconds.

Press to apply
02

Press

Apply to the wrist or chest. Pressure contact powers on the sensor — no buttons, no pairing, no charging.

Assign to patient
03

Assign

Scan the NFC tag with any smartphone. The patch is instantly linked to the patient's EHR record.

Monitor continuously
04

Monitor

HR, SpO₂, RR, and skin temperature stream via open BLE GATT to any dashboard. ARGOS AI scores deterioration risk every 15 minutes.

ARGOS Patch internal PCB layout

Built on open standards

No lock-in. No proprietary cloud.

  • ◆ Open BLE GATT — any scanner, any dashboard, no cloud lock-in
  • ◆ 84.8% AUC deterioration model — validated on real patient data
  • ◆ $9 per patient — same procurement model as ECG electrodes

"It goes on like a bandage. You don't pair it, charge it, or track it. When the patient leaves, it goes in the trash."

— ED Nurse perspective

By the numbers

0

To apply and register

0

Per patient, fully disposable

0

ROI for hospitals

0

Model AUC on real patient data

Market opportunity

$14 billion by 2030.

We're the only disposable, open-BLE, AI-scored sensor designed for the emergency department. The remote patient monitoring market is growing 20% annually — and the ED is the last ward it's reached.

Market positioning chart

For hospitals

Request early access.

Join our pilot program. We're placing ARGOS in 3 EDs this year — no cost, full clinical support.

For investors

Request investor deck.

84.8% AUC. $9 COGS. Open standards. Seed round open — 3 spots remaining.